Global Thought Leader | Breast Cancer & Precision Oncology

Executive Summary

Prof. Lee Soo Chin is a world-renowned Medical Oncologist and a leading advocate for breast cancer genetics, pharmacogenetics, and subcutaneous formulations. She leads the shift from IV to SubCut therapies, championing chemotherapy de-escalation, reduced patient “time toxicity,” and decentralized oncology care. Her leadership in global Phase I-III trials makes her a key scientific partner for peer-to-peer engagements.

Current Designations

• Senior Consultant & Former Head: Department of Medical Oncology, National University Cancer Institute, Singapore (NCIS).
• Professor: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS).
• Director: Cancer Genetics Program, NCIS.
• Senior Principal Investigator: Cancer Science Institute, Singapore (CSI).
• Drug Advisory Committee Member: Singapore Ministry of Health